Skip to main content
. 2019 Nov 11;176(Suppl 1):S297–S396. doi: 10.1111/bph.14752
Nomenclature http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2520 http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2521 http://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2525
HGNC, UniProt https://www.genenames.org/data/gene‐symbol‐report/#!/hgnc_id/HGNC:29799, http://www.uniprot.org/uniprot/Q86VZ5 https://www.genenames.org/data/gene‐symbol‐report/#!/hgnc_id/HGNC:28395, http://www.uniprot.org/uniprot/Q8NHU3 https://www.genenames.org/data/gene‐symbol‐report/#!/hgnc_id/HGNC:26320, http://www.uniprot.org/uniprot/Q96LT4
EC number http://www.genome.jp/dbget‐bin/www_bget?ec:2.7.8.27: ceramide + phosphatidylcholine ‐> sphingomyelin + diacylglycerol http://www.genome.jp/dbget‐bin/www_bget?ec:2.7.8.27: ceramide + phosphatidylcholine ‐> sphingomyelin + diacylglycerol http://www.genome.jp/dbget‐bin/www_bget?ec:2.7.8.‐: ceramide + http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2796> ceramide phosphoethanolamine
Inhibitors http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8835 (pIC50 5.7) [http://www.ncbi.nlm.nih.gov/pubmed/26314925?dopt=AbstractPlus] http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=8834 (pIC50 4.9) [http://www.ncbi.nlm.nih.gov/pubmed/24374347?dopt=AbstractPlus]
Comments Palmitoylation of sphingomyelin synthase 2 may allow targeting to the plasma membrane [http://www.ncbi.nlm.nih.gov/pubmed/19233134?dopt=AbstractPlus].